Rabbit Polyclonal DGKG antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human DGKG aa 450-700.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 10% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
IHC-P | WB | ICC/IF | |
---|---|---|---|
Human | Tested | Tested | Tested |
Mouse | Predicted | Predicted | Predicted |
Rat | Predicted | Predicted | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/100.00000 - 1/1000.00000 | Notes Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500.00000 - 1/3000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/100.00000 - 1/1000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Diacylglycerol kinase that converts diacylglycerol/DAG into phosphatidic acid/phosphatidate/PA and regulates the respective levels of these two bioactive lipids (PubMed:8034597). Thereby, acts as a central switch between the signaling pathways activated by these second messengers with different cellular targets and opposite effects in numerous biological processes (By similarity). Has no apparent specificity with regard to the acyl compositions of diacylglycerol (PubMed:8034597). Specifically expressed in the cerebellum where it controls the level of diacylglycerol which in turn regulates the activity of protein kinase C gamma. Through protein kinase C gamma, indirectly regulates the dendritic development of Purkinje cells, cerebellar long term depression and ultimately cerebellar motor coordination (By similarity).
DAGK3, DGKG, Diacylglycerol kinase gamma, DAG kinase gamma, Diglyceride kinase gamma, DGK-gamma
Rabbit Polyclonal DGKG antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human DGKG aa 450-700.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 10% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
DGKG also known as diacylglycerol kinase gamma is an important enzyme that phosphorylates diacylglycerol (DAG) to produce phosphatidic acid (PA). This enzyme possesses a molecular mass of approximately 90 kDa. DGKG is expressed in many tissues with particularly high levels in brain and muscle. Its expression in these areas indicates a significant role in neuronal signaling and muscle function.
DGKG influences various cellular processes by transforming diacylglycerol into phosphatidic acid. This enzymatic activity regulates the levels of DAG a critical second messenger involved in signal transduction. DGKG does not solely function on its own but is part of larger signaling complexes that mediate signal cascades. Through this involvement DGKG impacts cell growth differentiation and metabolism.
DGKG plays a significant role in the phosphatidylinositol signaling pathway. This pathway is essential for transmitting extracellular signals to intracellular responses primarily involving protein kinase C (PKC). DGKG also interacts with proteins such as RAS and RAF kinases indicating its participation in the MAPK/ERK pathway. These interactions highlight its contribution to transmitting signals that regulate cellular proliferation and differentiation.
DGKG shows associations with cancer and neurological disorders. The altered expression or function of DGKG may contribute to oncogenesis by affecting cell signaling pathways that control cell growth. Additionally its role in neuronal signaling links it to neurological conditions possibly through interactions with proteins such as PKC. DGKG's dysregulation in these contexts suggests its potential as a therapeutic target in managing these diseases.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
7.5% SDS PAGE
All lanes: Western blot - Anti-DGKG antibody (ab151967) at 1/1000 dilution
All lanes: H1299 lysate at 30 µg
Predicted band size: 89 kDa
Immunofluorescence analysis of methanol-fixed HeLa cells, labeling DGKG with ab151967 a 1/200 dilution.
Immunohistochemical analysis of paraffin embedded Human NCIN87 xenograft tissue labeling DGKG with ab151967 at a 1/500 dilution.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com